Indeed, while ACEA, a selective CB1 agonist, decreased the invasive potential of breast cancer stem cells, AM251, a selective CB1 antagonist, promoted invasion, indicating that CB1 receptors are involved in the regulation of stem cell properties [82]. The gene discussed is CNR1; the disease is breast cancer.